ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,982Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 49

$1.05M Total Retail Price of All Prescriptions

Rank: 2 out of 49

680 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wyoming
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 680 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

20% of this provider’s 680 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 13,503 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wyoming
LEVOTHYROXINE SODIUM 976 903 1 1
POTASSIUM CHLORIDE 699 598 2 9
OMEPRAZOLE 570 518 3 4
SIMVASTATIN 564 507 4 2
FUROSEMIDE 549 477 5 5
HYDROCODONE-ACETAMINOPHEN 533 425 S3 6 7
LISINOPRIL 522 438 7 3
METFORMIN HCL ER 361 326 8 38
WARFARIN SODIUM 353 287 9 8
METOPROLOL SUCCINATE 306 283 10 16
ATENOLOL 294 262 11 17
LOSARTAN POTASSIUM 250 238 12 14
GABAPENTIN 247 210 13 15
ALLOPURINOL 204 184 14 21
NEXIUM 184 169 15 27
METOPROLOL TARTRATE 178 174 16 11
DIOVAN 177 172 17 49
LANTUS 174 126 18 48
AMLODIPINE BESYLATE 167 159 19 6
CITALOPRAM HBR 160 147 20 18
DONEPEZIL HCL 155 142 21 24
CRESTOR 148 133 22 23
GLIMEPIRIDE 146 130 23 49
NAMENDA 132 120 24 41
CLOPIDOGREL 127 114 25 46
JANUVIA 119 105 26 44
PRAVASTATIN SODIUM 113 87 27 20
SERTRALINE HCL 111 92 28 22
PANTOPRAZOLE SODIUM 111 94 28 32
TRAZODONE HCL 109 41 30 54
DIGOXIN 106 100 31 39
ADVAIR DISKUS 106 99 31 28
SPIRONOLACTONE 105 75 33 26
OXYCODONE HCL 101 48 S2 34 80
MELOXICAM 101 101 34 31
ROPINIROLE HCL 99 90 36 66
FLUOXETINE HCL 97 84 37 60
TRILIPIX 96 69 38 128
CYMBALTA 93 56 39 33
SYMBICORT 92 48 40 68
BENICAR 91 89 41 99
AZITHROMYCIN 88 73 42 47
PLAVIX 86 79 43 88
ONGLYZA 86 78 43 135
OLANZAPINE 78 60 45 141
DIOVAN HCT 78 78 45 76
TAMSULOSIN HCL 77 58 47 25
RISPERIDONE 77 76 47 74
FINASTERIDE 74 66 49 114
SINGULAIR 73 68 50 70
GEMFIBROZIL 72 44 51 110
ATORVASTATIN CALCIUM 72 64 51 13
TRAMADOL HCL 71 68 53 29
SYNTHROID 70 58 54 45
TRIAMTERENE-HCTZ 69 64 55 43
ESCITALOPRAM OXALATE 68 68 56 52
VERAPAMIL ER 67 62 57 62
ABILIFY 66 28 58 150
METFORMIN HCL 65 56 59 10
METOLAZONE 65 49 59 90
IBUPROFEN 64 32 61 152
CIPROFLOXACIN HCL 64 52 61 76
FENTANYL 63 53 S2 63 59
MIRTAZAPINE 60 45 64 53
METOCLOPRAMIDE HCL 58 49 65 98
DILTIAZEM 24HR CD 57 57 66 65
SPIRIVA 53 53 67 37
RANITIDINE HCL 53 53 67 64
PROAIR HFA 53 40 67 58
PRADAXA 51 51 70 107
CELEBREX 51 32 70 57
LEXAPRO 50 42 72 170
LACTULOSE 50 28 72 170
CARVEDILOL 50 31 72 35
FLUTICASONE PROPIONATE 50 30 72 51
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 9, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.